SpryngerMWillemsMVan DammeH. Screening program of abdominal aortic aneurysm. Angiology. 2019;70(5):407–13.
2.
ShreibatiJBBakerLCHlatkyMAMellMW. Impact of Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act on abdominal ultrasonography use among Medicare beneficiaries. Arch Intern Med. 2012;172(19):1456–62.
3.
ThompsonSGAshtonHAGaoLScottRA; Multicentre Aneurysm Screening Study Group. Screening men for abdominal aortic aneurysm: 10-year mortality and cost-effectiveness results from the randomised multicentre aneurysm screening study. BMJ. 2009;338:b2307.
4.
ThompsonSGAshtonHAGaoLBuxtonMJScottRA; Multicentre Aneurysm Screening Study (MASS) Group. Final follow-up of the multicentre aneurysm screening study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg. 2012;99(12):1649–56.
5.
WanhainenALundkvistJBergqvistDBjorckM. Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg. 2005;41(5):741–751.
6.
KimLGThompsonSGBriggsAHBuxtonMJCampbellHE. How cost-effective is screening for abdominal aortic aneurysms?J Med Screen. 2007;14(1):46–52.
7.
GiardinaSPaneBSpinellaG. An economic evaluation of an abdominal aortic aneurysm screening program in Italy. J Vasc Surg. 2011;54(4):938–46.
8.
WanhainenALundkvistJBergqvistDBjorckM. Cost-effectiveness of screening women for abdominal aortic aneurysm. J Vasc Surg. 2006;43(5):908–14.
9.
GloverMJKimLGSweetingMJThompsonSGBuxtonMJ. Cost-effectiveness of the national health service abdominal aortic aneurysm screening programme in England. Br J Surg. 2014;101(8):976–82.
WilminkABQuickCRHubbardCSDayNE. Effectiveness and cost of screening for abdominal aortic aneurysm: results of a population screening program. J Vasc Surg. 2003;38(1):72–77.
12.
MellMWHlatkyMAShreibatiJBDalmanRLBakerLC. Late diagnosis of abdominal aortic aneurysms substantiates underutilization of abdominal aortic aneurysm screening for Medicare beneficiaries. J Vasc Surg. 2013;57(6):1519–23.
13.
OlchanskiMSWinnACohenJTNeumannPJ. Abdominal aortic aneurysm screening: how many life years lost from underuse of the Medicare screening benefit?J Gen Intern Med. 2014;29(8):1155–61.
14.
JohanssonMJorgensenKJBrodersenJ. Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.46% disease-specific mortality reduction?Lancet. 2016;387(10015):308–10.
15.
WhittakerJDMeechamLSummerourV. Outcome after turndown for elective abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2017;54(5):579–86.
16.
AhmadMMistryRHodsonJBradburyAW. How quickly do asymptomatic infrarenal abdominal aortic aneurysms grow and what factors affect aneurysm growth rates? Analysis of a single centre surveillance cohort database. Eur J Vasc Endovasc Surg. 2017;54(5):597–603.
17.
ChaikofELDalmanRLEskandariMK. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.e2.
18.
ParaskevasKI. Reconsidering the rupture risk potential of abdominal aortic aneurysms in high risk patients. Eur J Vasc Endovasc Surg. 2018;55(2):290.
19.
ParaskevasKILiapisCDHamiltonGMikhailidisDP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?Eur J Vasc Endovasc Surg. 2006;32(3):286–93.
20.
ParaskevasKILiapisCDHamiltonGMikhailidisDP. Are statins an option in the management of abdominal aortic aneurysms?Vasc Endovascular Surg. 2008;42(2):128–34.
21.
ParaskevasKIVeithFJLiapisCDMikhailidisDP. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update. Curr Vasc Pharmacol. 2013;11(1):112–20.
22.
LindholtJSJuulSFastingHHennebergEW. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. Eur J Vasc Endovasc Surg. 2002;23(1):55–60.
23.
LindholtJSJuulSFastingHHennebergEW. Cost-effectiveness analysis of screening for abdominal aortic aneurysms based on five year results from a randomised hospital based mass screening trial. Eur J Vasc Endovasc Surg. 2006;32(1):9–15.
24.
ParaskevasKIBrianaDDMalamitsi-PuchnerA. The benefits of screening programmes. Lancet. 2016;387(10028):1617–18.
